The mood at the annual meeting of the American Society of Cell and Gene Therapy isn’t amazing. The biotech market has been ...

Scientists present current evidence for a new gene therapy for Duchenne muscular dystrophy called delandistrogene moxeparvovec.

Cell and gene therapies offer potential new therapeutics but are currently constrained by complex and inefficient manufacturing strategies.

Despite holding promise in a range of disease states, a variety of challenges prevent cell and gene therapies (CGTs) from ...

Randee’s cancer had metastasized. When her doctor tested her for the PIK3CA gene mutation, she was able to make informed ...

The scientists at the University of California, San Francisco and Johns Hopkins University in Baltimore injected an antisense ...

US FDA accepts and grants priority review status to Regenxbio’s BLA for clemidsogene lanparvovec to treat Mucopolysaccharidosis II: Rockville, Maryland Thursday, May 15, 2025, 1 ...

World Thalassemia Day was observed on 8 May. India records between 10,000 and 15,000 new cases of Thalassemia Major every ...

Good evening and welcome to the Dyadic International First Quarter 2025 Financial Results Conference Call. Currently, all participants are in a listen-only mode. Following management's prepared ...

Polen Capital, an investment management company, released its “Polen U.S. Small Company Growth Strategy” first-quarter 2025 ...

BioCardia, Inc. ( NASDAQ: BCDA) Q1 2025 Earnings Conference Call May 14, 2025, 16:30 PM ET Peter Altman - President and CEO David McClung - CFO Miranda Peto - IR Joe Pantginis - H.C. Wainwright Laura ...

In a new study published in Nature, researchers at the University of Chicago Medicine Comprehensive Cancer Center explore a ...